Le Lézard
Classified in: Health, Science and technology
Subject: Conference

AVROBIO, Inc. to Present at Chardan's 3rd Annual Genetic Medicines Conference


AVROBIO, Inc. (NASDAQ:AVRO), a Phase 2 clinical-stage gene therapy company, today announced that Geoff MacKay, President and CEO of AVROBIO, will present at Chardan's 3rd Annual Genetic Medicines Conference on Monday, October 7, 2019.

Chardan's 3rd Annual Genetic Medicines Conference
Date: Monday, October 7, 2019
Time: 3:45 p.m. ET
Location: The Westin Grand Central Hotel, New York, NY

A live webcast of the presentation will be available on the investors section of the AVROBIO company website at www.avrobio.com. After the live webcast, the event will remain archived on the AVROBIO website for 90 days.

About AVROBIO, Inc.

AVROBIO, Inc. is a leading, Phase 2 gene therapy company focused on the development of its investigational gene therapy, AVR-RD-01, in Fabry disease, as well as additional gene therapy programs in other lysosomal storage disorders including Gaucher disease, cystinosis and Pompe disease. The Company's platotm platform includes a proprietary vector system, automated cell manufacturing solution and refined conditioning regimen deploying therapeutic drug monitoring. AVROBIO is headquartered in Cambridge, MA and has offices in Toronto, ON. For additional information, visit www.avrobio.com.


These press releases may also interest you

at 03:00
MedAlliance has announced enrollment of the first patient in its study of SELUTION SLRtm 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Program'. The SELUTION SLR (Sustained...

at 03:00
Uniform Advantage (UA), a multi-channel retailer of medical uniforms for medical and hospitality industries, develops an innovative exclusive scrub collection for men and women, focused on comfort, durability and functionality. "We designed Movement...

10 jui 2020
Johns Hopkins University filed suit in federal court Friday in an effort to stop a Trump administration rule change that would severely impact nearly 5,000 international students at the university. The decision to abruptly rescind accommodations for...

10 jui 2020
Worries and anxiety about COVID-19 and its impact can be overwhelming for people with spinal cord disease or injury and social distancing makes it even more challenging. "For folks with a spinal cord injury, the COVID-19 pandemic can induce symptoms...

10 jui 2020
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ), a leading independent third-party administrator (TPA) of self-funded medical plans, has received an investment from Abry Partners LP, a private investment firm...

10 jui 2020
MPX International Corporation ("MPX International", "MPXI" or the "Corporation") today reports financial results for its second quarter, the three and six month period ended March 31, 2020. All figures are presented...



News published on 3 october 2019 at 08:05 and distributed by: